Symposia

Dec
06

Education Credit

2.5 CME

Nurses may claim up to 2.5 contact hours for this session.

University of Minnesota approves this knowledge-based activity for 2.5 contact hours (0.25 CEUs). UAN JA0000810-9999-19-082-L01-P. Initial Release Date: 12/6/19.

Spanish Symposium: Neuromodulation for Treatment of Medically-refractory Epilepsy

Convention Center, Rooms 339-342
3:30 PM-6:00 PM
APPs
Behavioral Health Providers
Clinicians
Fellows/Trainees
Nurses
Pharmacists
Scientists
Technicians

This symposium will review the different neuromodulation therapies used to treat medically refractory epilepsy and how to determine the best candidate for each of these modalities. The speakers will describe how to define medically-refractory epilepsy; review the work-up required to determine if a patient is a good candidate for neuromodulation; assess which of the modalities is the most appropriate based on the epilepsy syndrome; and describe vagal nerve stimulation, deep brain stimulation and responsive brain stimulation.

Learning Objectives

Following participation in this activity, participants will be able to:

  • Describe the definition of medically-refractory epilepsy
  • Identify patients who are potential candidates for treatment with neuromodulation
  • Appreciate the different neuromodulation treatment options available for patients with refractory epilepsy
  • Describe the work-up required to determine appropriate candidates for neuromodulation

 

 

Co-Chairs: David King-Stephens, MD and Jorge Burneo, MD, MSPH

Introduction, David King-Stephens, MD
Refractoriness: Past, Present and Future, Patricia Braga, MD, MSc
Functional Neuroimaging in Refractory Epilepsy: Where Are We Now and Where Are We Going? Antonio Jesus Donaire Pedraza, MD, PhD
VNS: Who Are the Best Candidates? Efficacy and Outcome During Long-term Follow-up, Walter Silva, MD
Responsive Neurostimulation: When and for Whom? Kamil Detyniecki, MD
Deep Brain Stimulation for Epilepsy: Patient Selection, Targets, Programming and Outcome, Arthur Cukiert, MD, PhD
Panel Discussion and Conclusions: Jorge Burneo, MD, MSPH